BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27161997)

  • 61. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.
    Lu PJ; Santibanez TA; Williams WW; Zhang J; Ding H; Bryan L; O'Halloran A; Greby SM; Bridges CB; Graitcer SB; Kennedy ED; Lindley MC; Ahluwalia IB; LaVail K; Pabst LJ; Harris L; Vogt T; Town M; Singleton JA;
    MMWR Surveill Summ; 2013 Oct; 62(4):1-28. PubMed ID: 24157710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women--10 states, 2009-10 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Dec; 59(47):1541-5. PubMed ID: 21124293
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population.
    Capri S; Barbieri M; de Waure C; Boccalini S; Panatto D
    Hum Vaccin Immunother; 2018 Jun; 14(6):1331-1341. PubMed ID: 29425079
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types.
    Van Bellinghen LA; Marijam A; Tannus Branco de Araujo G; Gomez J; Van Vlaenderen I
    Braz J Infect Dis; 2018; 22(1):1-10. PubMed ID: 29352897
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
    McMorrow ML; Tempia S; Walaza S; Treurnicht FK; Ramkrishna W; Azziz-Baumgartner E; Madhi SA; Cohen C
    Vaccine; 2019 Jan; 37(1):25-33. PubMed ID: 30471956
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
    Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
    BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
    Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
    JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Technical guidelines for seasonal influenza vaccination in China, 2018-2019].
    Feng LZ; Peng ZB; Wang DY; Yang P; Yang J; Zhang YY; Chen J; Jiang SQ; Xu LL; Kang M; Chen T; Zheng YM; Zheng JD; Qin Y; Zhao MJ; Tan YY; Li ZJ; Feng ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1413-1425. PubMed ID: 30462947
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China.
    Jiang M; Li P; Wang W; Zhao M; Atif N; Zhu S; Fang Y
    Vaccine; 2020 Jan; 38(5):1057-1064. PubMed ID: 31787414
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Global Influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenza.
    Macias AE; Precioso AR; Falsey AR;
    Influenza Other Respir Viruses; 2015 Aug; 9 Suppl 1(Suppl 1):31-7. PubMed ID: 26256293
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan.
    Hoshi SL; Seposo X; Okubo I; Kondo M
    Vaccine; 2018 Aug; 36(34):5133-5140. PubMed ID: 30041878
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.
    Smith KJ; Raviotta JM; DePasse JV; Brown ST; Shim E; Patricia Nowalk M; Zimmerman RK
    Am J Prev Med; 2016 May; 50(5):600-608. PubMed ID: 26868283
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Technical guidelines for seasonal influenza vaccination in China (2018-2019)].
    Feng LZ; Peng ZB; Wang DY; Yang P; Yang J; Zhang YY; Chen J; Jiang SQ; Xu LL; Kang M; Chen T; Zheng YM; Zheng JD; Qin Y; Zhao MJ; Tan YY; Li ZJ; Feng ZJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Nov; 52(11):1101-1114. PubMed ID: 30419692
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness of maternal immunization with trivalent inactivated influenza vaccine in pregnant women and their infants.
    Mølgaard-Nielsen D; Fischer TK; Krause TG; Hviid A
    J Intern Med; 2019 Oct; 286(4):469-480. PubMed ID: 31259452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
    de Boer PT; Crépey P; Pitman RJ; Macabeo B; Chit A; Postma MJ
    Value Health; 2016 Dec; 19(8):964-975. PubMed ID: 27987647
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
    Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
    Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: a Markov cohort model based on serial study participant hemoagglutination inhibition titers.
    Werker GR; Sharif B; Sun H; Cooper C; Bansback N; Anis AH
    Vaccine; 2014 Feb; 32(6):677-84. PubMed ID: 24355089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.